An analysis of the NCDR PVI Registry provides a rare look at practice variations across hospitals in the US.

Future research is needed to elucidate the mechanisms by which CHD affects cognition, and whether that’s causative, experts say.

No adverse events have occurred as of yet, but there remains the potential for vessel injury, additional interventions, and death.

Aortic stenosis patients take a hit with surgery and may not recover function to the same extent as TAVR patients, says expert.

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short learning curve.

There’s still a need to compare transcarotid with subclavian and transcaval access, but experts agree: stay out of the thorax.

In a session devoted to what technology might win out in the mitral valve space, experts said multiple therapies are needed.

By one estimate, 65% don’t get referred for aortic valve replacement, posing questions for who and how to track patients with early AS.

The data support more aggressive follow-up for women with preeclampsia and gestational hypertension, one expert says.

A 6-year registry snapshot hints that TAVR stroke rates have been stable, spurring questions for low-risk patients and brain debris.

Investigators say there is little information to guide the timing of PCI, but these new data suggest it’s safe before, with, or after TAVR.

The new document, created by an international team, touches on decision-making, de-escalation of therapy, and the trials ahead.